The development of patient specific liver cell lines from stem cells is a significant advance in the battle against liver diseases. Liver disease is the fifth most common cause of mortality in many developed countries and unlike the other leading causes of death, the rate of liver related mortality is increasing.<br/>
Professor Michael Schneider describes a new approach to treating heart attack and cardiomyopathy using stem cells.
A parasite estimated to afflict as many as 12 million people worldwide relies on a family of genes that should make it vulnerable to compounds developed to treat cancer and other disorders, researchers at Washington University School of Medicine in St. Louis have found.